News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CytRx Corporation (CYTR) Receives Shares of ADVENTRX Pharmaceuticals Inc. (ANX) in SynthRx, Inc. Transaction



4/11/2011 10:02:52 AM

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical company specializing in oncology, has received approximately 163,000 shares of common stock in ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) in exchange for its 19.1% ownership position in SynthRx, Inc., following the completion of ADVENTRX’s previously announced acquisition of SynthRx. The last sale price of ADVENTRX shares on the NYSE Amex on April 8, 2011 was $2.34.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES